NEUROTECH USA, INC.
Patent Owner
Stats
- 38 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 01, 2018 most recent publication
Details
- 38 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,521 Total Citation Count
- Mar 10, 1994 Earliest Filing
- 20 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9265814 Micronized device for the delivery of biologically active molecules and methods of use thereofDec 18, 06Feb 23, 16[A61K, A01N]
9149427 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereofNov 30, 11Oct 06, 15[A61K, C12N, A61L, C07K]
7820195 Micronized device for the delivery of biologically active molecules and methods of use thereofDec 18, 06Oct 26, 10[A61K]
7115257 ARPE-19 as a platform cell line for encapsulated cell-based deliveryApr 06, 00Oct 03, 06[A61K]
6627422 Device containing cell-supporting yarn matrix encapsulated in a semi-permeable membraneDec 21, 00Sep 30, 03[A61F, C12N]
6361771 ARPE-19 as a platform cell line for encapsulated cell-based deliveryApr 05, 00Mar 26, 02[A61K, C12N, A61M]
6303136 Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membraneApr 12, 99Oct 16, 01[A01N, A61F, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0150,796 Cryopreserved Implantable Cell Culture Devices and Uses ThereofAbandonedMay 30, 13Jun 04, 15[A61K, A61L]
2015/0024,024 Cell Lines That Produce Prostaglandin F2 Alpha (PGF2A) And Uses ThereofAbandonedApr 21, 10Jan 22, 15[A61K]
2011/0111,008 Use of PEDF in an Encapsulated Cell-Based Delivery SystemAbandonedOct 06, 10May 12, 11[A61K, A61F, C12N]
2010/0272,780 CELL LINES THAT PRODUCE PROSTAGLANDIN F2 ALPHA (PGF2a) AND USES THEREOFAbandonedApr 21, 10Oct 28, 10[A61K, A61F, C12N, A61P]
2009/0269,319 ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based DeliveryAbandonedJul 08, 09Oct 29, 09[A61K, A61P]
2009/0269,389 ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based DeliveryAbandonedJul 07, 09Oct 29, 09[C12N, A61P]
2007/0071,734 ARPE-19 as platform cell line for encapsulated cell-based deliveryAbandonedOct 03, 06Mar 29, 07[A61K, A61F]
6878544 Retinal cell lines with extended life-span and their applicationsExpiredApr 27, 00Apr 12, 05[C12N]
6264941 Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsulesExpiredJan 25, 99Jul 24, 01[A61K]
6183735 Immortalized retinal pigmentary epithelial cell lines and their applicationsExpiredJan 22, 98Feb 06, 01[A61K, C07H, C12N]
5935849 Methods and compositions of growth control for cells encapsulated within bioartificial organsExpiredJul 20, 94Aug 10, 99[C12N]
5858747 Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriersExpiredMay 23, 95Jan 12, 99[C07K]
5853717 Methods and compositions of growth control for cells encapsulated within bioartificial organsExpiredMay 23, 95Dec 29, 98[A01N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.